Lipids [BR:br08002]
FA Fatty acyls
FA08 Fatty amides
FA0802 N-acyl amines
C06866 Capsaicin
Phytochemical compounds [BR:br08003]
Amino acid related compounds
Others
Capsaicinoids and derivatives
C06866 Capsaicin
Secondary metabolites in pathway maps [br08011.html]
Biosynthetic pathways and modules of secondary metabolites
C06866
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M02A TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN
M02AB Capsaicin and similar agents
M02AB01 Capsaicin
D00250 Capsaicin (JAN/USP) <US>
N NERVOUS SYSTEM
N01 ANESTHETICS
N01B ANESTHETICS, LOCAL
N01BX Other local anesthetics
N01BX04 Capsaicin
D00250 Capsaicin (JAN/USP) <US>
Risk category of Japanese OTC drugs [BR:br08312]
Third-class OTC drugs
Inorganic and organic chemicals
Capsaicin
D00250 Capsaicin (JAN/USP)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG02030 Anesthetics
DG01675 Local anesthetic
D00250 Capsaicin
Target-based classification of drugs [BR:br08310]
Ion channels
Voltage-gated ion channels
Transient receptor potential channels
TRPV1
D00250 Capsaicin (JAN/USP) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D00250
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D00250
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D00250
